All Stories

  1. Decision making for the central compartment in differentiated thyroid cancer
  2. Surgical margins in head and neck cancer: Intra- and postoperative considerations
  3. Refining definitions within low-risk differentiated thyroid cancers
  4. How phenotype guides management of the neuroendocrine carcinomas of the larynx
  5. Differentiated thyroid cancer: A retrospective evaluation of the impact of changes to disease management guidelines on patients in South East Scotland
  6. Image-guided chemical and thermal ablations for thyroid disease: Review of efficacy and complications
  7. Molecular markers in well-differentiated thyroid cancer
  8. Ensuring patient safety when implementing a new diagnostic pathway for thyroid nodules
  9. Optimization of the risk-benefit ratio of differentiated thyroid cancer treatment
  10. Sacrifice and extracranial reconstruction of the common or internal carotid artery in advanced head and neck carcinoma: Review and meta-analysis
  11. Prognostic value of lymph node ratio in head and neck squamous cell carcinoma
  12. Head and Neck Cancer: A Review of the Impact of Treatment Delay on Outcome
  13. Causes of overdiagnosis in thyroid carcinoma
  14. The central compartment – Center of controversy, confusion, and concern in management of differentiated thyroid cancer
  15. Erratum to “Erratum to “The SCARE guidelines: Consensus-based surgical case report guidelines” [Int. J. Surg. 34 (2016) 180–186]” [Int. J. Surg. 36 (2016) 396]
  16. Prophylactic “First-Step” Central Neck Dissection (Level 6) Does not Increase Morbidity After (Total) Thyroidectomy
  17. The STROCSS statement: Strengthening the Reporting of Cohort Studies in Surgery
  18. The use of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange in 17 cases of subglottic stenosis
  19. Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond
  20. Analysis of the incidence and factors predictive of outcome in patients with head and neck cancer with pulmonary nodules
  21. Implications of extra nodal extension in differentiated thyroid cancer
  22. How phenotype guides management of non-conventional squamous cell carcinomas of the larynx?
  23. Ethical Issues in Non-intervention Trials for Thyroid Cancer
  24. How Phenotype Guides Management of the Most Common Malignant Salivary Neoplasms of the Larynx?
  25. Nasal juvenile angiofibroma: Current perspectives with emphasis on management
  26. Differentiated and Medullary Thyroid Cancer: Surgical Management of Cervical Lymph Nodes
  27. Surgical management of primary thyroid tumours
  28. Do salivary bypass tubes lower the incidence of pharyngocutaneous fistula following total laryngectomy? A retrospective analysis of predictive factors using multivariate analysis
  29. Erratum to “The SCARE guidelines: Consensus-based surgical case report guidelines” [Int. J. Surg. 34 (2016) 180–186]
  30. Preferred reporting of case series in surgery; the PROCESS guidelines
  31. Management of pulmonary nodules in head and neck cancer patients – Our experience and interpretation of the British Thoracic Society Guidelines
  32. The SCARE Statement: Consensus-based surgical case report guidelines
  33. Operative management of locally advanced, differentiated thyroid cancer
  34. Small cell neuroendocrine carcinoma of tracheostomy site in a patient with a history of juvenile laryngeal papillomatosis
  35. The Impact of Family History on Non-Medullary Thyroid Cancer
  36. Pattern of neck recurrence after lateral neck dissection for cervical metastases in papillary thyroid cancer
  37. Treatment of large tracheal defects after resection: Laryngotracheal release and tracheal replacement
  38. Wysoko zróżnicowany rak tarczycy — czy nie leczysz swoich pacjentów zbyt intensywnie?
  39. Chapter-14 Management of Well-Differentiated Thyroid Cancer
  40. The surgical approach to managing differentiated thyroid cancer
  41. The Surgical Approach to Differentiated Thyroid Cancer
  42. Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection
  43. 8. Ultrasound for assessment of thyroid nodules at a district general hospital setting
  44. Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?
  45. Microscopic Positive Margins in Differentiated Thyroid Cancer Is Not an Independent Predictor of Local Failure
  46. Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer
  47. Role of RAI in the management of incidental N1a disease in papillary thyroid cancer
  48. Prognostic Value of Vascular Invasion in Well-Differentiated Papillary Thyroid Carcinoma
  49. Undetectable Thyroglobulin Levels in Poorly Differentiated Thyroid Carcinoma Patients Free of Macroscopic Disease After Initial Treatment: Are They Useful?
  50. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer
  51. Thyrotropin Suppression Increases the Risk of Osteoporosis Without Decreasing Recurrence in ATA Low- and Intermediate-Risk Patients with Differentiated Thyroid Carcinoma
  52. Tongue Metastasis from a Poorly Differentiated Urothelial Carcinoma of the Bladder
  53. Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates
  54. Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer
  55. Peer review report 1 on “Initial learning curve of single-incision transaxillary robotic hemi- and total thyroidectomy – A single team experience from Europe”
  56. Central Lymph Node Characteristics Predictive of Outcome in Patients with Differentiated Thyroid Cancer
  57. Comparable outcomes for patients with pT1a and pT1b differentiated thyroid cancer: Is there a need for change in the AJCC classification system?
  58. Multi-Organ Distant Metastases Confer Worse Disease-Specific Survival in Differentiated Thyroid Cancer
  59. Level 7 Disease Does Not Confer Worse Outcome than Level 6 Disease in Differentiated Thyroid Cancer
  60. Surgical Diagnosis
  61. The impact of nodal status on outcome in older patients with papillary thyroid cancer
  62. Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS)
  63. Outcomes in Patients With Poorly Differentiated Thyroid Carcinoma
  64. Should elective neck dissection be routinely performed in patients undergoing salvage total laryngectomy?
  65. Well differentiated thyroid cancer: Are we over treating our patients?
  66. Can we predict which patients are likely to develop severe complications following reconstruction for osteoradionecrosis?
  67. Observation of clinically negative central compartment lymph nodes in papillary thyroid carcinoma
  68. A multi-institutional international study of risk factors for hematoma after thyroidectomy
  69. Pathologically Determined Tumor Volume vs Pathologic T Stage in the Prediction of Outcome After Surgical Treatment of Oropharyngeal Squamous Cell Carcinoma
  70. Factors predictive of outcome following primary total laryngectomy for advanced squamous cell carcinoma
  71. Time interval between primary radiotherapy and salvage laryngectomy: a predictor of pharyngocutaneous fistula formation
  72. Thyroid metastasectomy
  73. Poorly Differentiated Thyroid Carcinoma Presenting with Gross Extrathyroidal Extension: 1986–2009 Memorial Sloan-Kettering Cancer Center Experience
  74. Selective neck dissection as a therapeutic option in management of squamous cell carcinoma of unknown primary
  75. Management of regional nodes in Thyroid Cancer
  76. Radioactive iodine use in patients with low- and intermediate-risk papillary thyroid cancer
  77. Thyroid cancer: Surgery for the primary tumor
  78. The Results of Selective Use of Radioactive Iodine on Survival and on Recurrence in the Management of Papillary Thyroid Cancer, Based on Memorial Sloan-Kettering Cancer Center Risk Group Stratification
  79. The neoplastic goitre
  80. Targeted therapy in thyroid cancer
  81. Direct skin involvement of cervical lymph node metastasis from mucosal squamous cell carcinoma of the head and neck
  82. Selective Use of Radioactive Iodine in Intermediate-Risk Papillary Thyroid Cancer
  83. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer— is there a need for radioactive iodine therapy?
  84. Pre-operative tracheostomy does not impact on stomal recurrence and overall survival in patients undergoing primary laryngectomy
  85. Modified extended Kocher incision for total thyroidectomy with lateral compartment neck dissection - a critical appraisal of surgical access and cosmesis in 31 patients
  86. The Impact of Distant Metastases at Presentation on Prognosis in Patients with Differentiated Carcinoma of the Thyroid Gland
  87. Outcome of patients with early T1 and T2 squamous cell carcinoma of the base of tongue managed by conventional surgery with adjuvant postoperative radiation
  88. Nomogram for selecting thyroid nodules for ultrasound‐guided fine‐needle aspiration biopsy based on a quantification of risk of malignancy
  89. The Impact of Distant Metastases at Presentation on Prognosis in Patients Differentiated Carcinoma of the Thyroid Gland
  90. Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy
  91. Sentinel Lymph Node Biopsy for T1/T2 Oral Cavity Squamous Cell Carcinoma—A Prospective Case Series
  92. Post-operative wound infection in salvage laryngectomy: does antibiotic prophylaxis have an impact?
  93. Changing trends in well differentiated thyroid carcinoma over eight decades
  94. The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer
  95. Surgical management of squamous cell carcinoma of the soft palate: Factors predictive of outcome
  96. An integrated simulator for endolaryngeal surgery
  97. Incidence and Significance of Delphian Node Metastasis in Papillary Thyroid Cancer
  98. Disease-Related Death in Patients Who Were Considered Free of Macroscopic Disease After Initial Treatment of Well-Differentiated Thyroid Carcinoma
  99. Factors Predicting Outcome in Malignant Minor Salivary Gland Tumors of the Oropharynx
  100. Nomogram for predicting malignancy in thyroid nodules using clinical, biochemical, ultrasonographic, and cytologic features
  101. Surgical Management of Metastases to the Thyroid Gland
  102. Electronic Synoptic Operative Reporting for Thyroid Surgery using an Electronic Data Management System: Potential for Prospective Multicenter Data Collection
  103. Thyroid Isthmusectomy for Well-Differentiated Thyroid Cancer
  104. Minimum dataset for endolaryngeal surgery: pilot study
  105. Vocal function following discharge from intensive care
  106. Teleconferencing in the management of head and neck cancer
  107. The impact of methicillin-resistant Staphylococcus aureus on ENT practice
  108. A prospective study comparing conventional methods against a structured method of gaining patients’ informed consent for tonsillectomy
  109. Labial pit and ectopic salivary gland tissue
  110. Central Retinal Artery Occlusion following a Total Laryngectomy
  111. Faculty of 1000 evaluation for Long-Term Outcomes Following Low-Dose Radioiodide Ablation for Differentiated Thyroid Cancer.
  112. Faculty of 1000 evaluation for Merkel cell carcinoma: a systematic review of ENT presentations.